Core Laboratories Inc.

NYSE:CLB Voorraadrapport

Marktkapitalisatie: US$953.6m

Core Laboratories Beheer

Beheer criteriumcontroles 2/4

De CEO Core Laboratories is Larry Bruno, benoemd in Feb2018, heeft een ambtstermijn van 6.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 7.99M, bestaande uit 11.1% salaris en 88.9% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.35% van de aandelen van het bedrijf, ter waarde $ 3.31M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.8 jaar en 4.5 jaar.

Belangrijke informatie

Larry Bruno

Algemeen directeur

US$8.0m

Totale compensatie

Percentage CEO-salaris11.1%
Dienstverband CEO6.8yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn4.8yrs
Gemiddelde ambtstermijn bestuur4.5yrs

Recente managementupdates

It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

May 02
It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

Recent updates

Is Core Laboratories (NYSE:CLB) Using Too Much Debt?

Nov 12
Is Core Laboratories (NYSE:CLB) Using Too Much Debt?

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?

Sep 19
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 38% Discount?

What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E

Aug 14
What You Can Learn From Core Laboratories Inc.'s (NYSE:CLB) P/E

We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt

Jul 15
We Think Core Laboratories (NYSE:CLB) Can Stay On Top Of Its Debt

These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong

Jun 25
These Return Metrics Don't Make Core Laboratories (NYSE:CLB) Look Too Strong

It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

May 02
It's Unlikely That Core Laboratories Inc.'s (NYSE:CLB) CEO Will See A Huge Pay Rise This Year

Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Mar 26
Is Core Laboratories Inc. (NYSE:CLB) Trading At A 25% Discount?

Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Mar 02
Why We're Not Concerned About Core Laboratories Inc.'s (NYSE:CLB) Share Price

Core Laboratories: EPS Miss, But Beneficial Outlook About Exploration Efforts

Nov 09

Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Sep 08
Returns On Capital At Core Laboratories (NYSE:CLB) Paint A Concerning Picture

Core Laboratories: 'Spooked The Herd' In June, Things Might Be Looking Up

Aug 16

Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

Jul 05
Core Laboratories Inc.'s (NYSE:CLB) Earnings Haven't Escaped The Attention Of Investors

The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence

May 25
The Returns On Capital At Core Laboratories (NYSE:CLB) Don't Inspire Confidence

Analyse CEO-vergoeding

Hoe is Larry Bruno's beloning veranderd ten opzichte van Core Laboratories's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

US$26m

Jun 30 2024n/an/a

US$24m

Mar 31 2024n/an/a

US$38m

Dec 31 2023US$8mUS$887k

US$37m

Sep 30 2023n/an/a

US$41m

Jun 30 2023n/an/a

US$39m

Mar 31 2023n/an/a

US$24m

Dec 31 2022US$6mUS$820k

US$19m

Sep 30 2022n/an/a

US$15m

Jun 30 2022n/an/a

US$9m

Mar 31 2022n/an/a

US$10m

Dec 31 2021US$7mUS$820k

US$20m

Sep 30 2021n/an/a

US$31m

Jun 30 2021n/an/a

US$33m

Mar 31 2021n/an/a

US$19m

Dec 31 2020US$5mUS$820k

-US$97m

Sep 30 2020n/an/a

-US$101m

Jun 30 2020n/an/a

-US$80m

Mar 31 2020n/an/a

-US$55m

Dec 31 2019US$3mUS$531k

US$94m

Sep 30 2019n/an/a

US$92m

Jun 30 2019n/an/a

US$90m

Mar 31 2019n/an/a

US$96m

Dec 31 2018US$3mUS$425k

US$80m

Compensatie versus markt: De totale vergoeding ($USD 7.99M ) Larry } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.20M ).

Compensatie versus inkomsten: De beloning van Larry is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Larry Bruno (65 yo)

6.8yrs

Tenure

US$7,988,083

Compensatie

Mr. Lawrence V. Bruno, also known as Larry, serves as Chairman of Supervisory Board and Chief Exertive Officer at Core Laboratories N.V. since May 20, 2020. He has been Supervisory Director of Core Laborat...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Lawrence Bruno
Chairman of the Board6.8yrsUS$7.99m0.35%
$ 3.3m
Christopher Hill
Senior VP & CFO6.5yrsUS$2.88m0.15%
$ 1.5m
Gwendolyn Gresham
Senior Vice President of Corporate Development & Investor Relations8.3yrsUS$1.47m0.051%
$ 486.6k
Mark Tattoli
Senior VP3.3yrsUS$1.46m0.028%
$ 269.9k
Sow Hang Teo
VP, Treasurer & Chief Accounting Officerless than a yeargeen gegevens0.015%
$ 145.4k
Leslie Linklater
Vice President Peopleless than a yeargeen gegevensgeen gegevens
Jacobus Schouten
Managing Directorno dataUS$174.34kgeen gegevens
J. Dumas
Senior VP of Production Enhancement & Business Development4.8yrsgeen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CLB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Lawrence Bruno
Chairman of the Board6.5yrsUS$7.99m0.35%
$ 3.3m
Curtis Anastasio
Independent Director1.4yrsUS$190.79k0.014%
$ 130.4k
Katherine Murray
Independent Director2.5yrsUS$218.79k0.025%
$ 241.7k
Harvey Klingensmith
Independent Director4.5yrsUS$221.29k0.070%
$ 663.0k
Michael Straughen
Independent Director8.8yrsUS$243.79k0.049%
$ 464.9k
Martha Carnes
Lead Independent Director8.8yrsUS$268.79k0.079%
$ 751.7k
Kwaku Temeng
Independent Director3.5yrsUS$227.54k0.035%
$ 329.3k

4.5yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CLB wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.5 jaar).